Adverum Clinical Site 126 — Phoenix, Arizona

Adverum Clinical Site 126 is a clinical research site located in Phoenix, Arizona, United States 85053.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Adverum Clinical Site 126 has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD, Neovascular Age-related Macular Degeneration.

Sponsors: Adverum Biotechnologies, Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Adverum Clinical Site 126?

Adverum Clinical Site 126 has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Adverum Clinical Site 126 conducted?

Adverum Clinical Site 126 has 2 clinical trials on record, with 2 currently active. Their work covers Neovascular Age-Related Macular Degeneration (nAMD), Wet AMD, Neovascular Age-related Macular Degeneration.

Is Adverum Clinical Site 126 accredited by Crixeo Health?

Adverum Clinical Site 126 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Adverum Clinical Site 126?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.